Akoya Biosciences, Inc.
AKYA
$1.27
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.10% | 18.45% | 36.79% | -24.90% | 42.77% |
| Total Depreciation and Amortization | -12.06% | -29.15% | -7.71% | -3.30% | 10.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.96% | -57.70% | -34.78% | 161.61% | -25.34% |
| Change in Net Operating Assets | 146.42% | 69.24% | -559.15% | -27.36% | -181.40% |
| Cash from Operations | 46.60% | 32.70% | 6.46% | -5.40% | 44.20% |
| Capital Expenditure | -75.42% | 47.84% | 88.05% | -0.75% | 31.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -785.81% | -100.00% |
| Cash from Investing | 553.37% | 1,664.78% | 736.26% | -887.88% | -102.68% |
| Total Debt Issued | -- | -- | -- | -- | 0.00% |
| Total Debt Repaid | -178.89% | 5.14% | 0.00% | -22.30% | -10.43% |
| Issuance of Common Stock | 128.57% | -52.94% | -99.95% | -37.93% | -96.28% |
| Repurchase of Common Stock | -- | -- | -- | -58.51% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -11.44% | 36.17% | 100.00% |
| Cash from Financing | -104.39% | -6.38% | -104.59% | -5.97% | 7.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -115.82% | 124.53% | -112.42% | -401.29% | -78.12% |